These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 2506868)
1. Sub-inhibitory and post-antibiotic effects of an optically active isomer of ofloxacin. Tanaka M; Une T; Osada Y Arzneimittelforschung; 1989 Jul; 39(7):750-4. PubMed ID: 2506868 [TBL] [Abstract][Full Text] [Related]
2. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus]. Cetinkaya E; Coban AY; Durupinar B Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076 [TBL] [Abstract][Full Text] [Related]
3. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. Lewin CS; Amyes SG J Med Microbiol; 1989 Nov; 30(3):227-31. PubMed ID: 2479750 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin. Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375 [TBL] [Abstract][Full Text] [Related]
5. Bactericidal activities of ofloxacin and its optically active isomer (DR-3355) on non-growing cells of Escherichia coli and Pseudomonas aeruginosa. Tanaka M; Otsuki M; Nishino T Chemotherapy; 1992; 38(1):21-7. PubMed ID: 1618000 [TBL] [Abstract][Full Text] [Related]
6. Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model. Xerri L; Broggio R; Guerra L Chemioterapia; 1986 Apr; 5(2):83-7. PubMed ID: 3085961 [TBL] [Abstract][Full Text] [Related]
7. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin. Zeiler HJ Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261 [TBL] [Abstract][Full Text] [Related]
8. Influence of temperature on mutational resistance to 4-quinolones. Parte AC; Smith JT Arzneimittelforschung; 1996 Apr; 46(4):429-32. PubMed ID: 8740093 [TBL] [Abstract][Full Text] [Related]
9. Influence of ciprofloxacin on the ultrastructure of gram-negative and gram-positive bacteria. Voigt WH; Zeiler HJ Arzneimittelforschung; 1985; 35(10):1600-3. PubMed ID: 2934069 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. Odenholt I; Cars O J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293 [TBL] [Abstract][Full Text] [Related]
11. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin]. Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519 [TBL] [Abstract][Full Text] [Related]
12. Activity of 4-quinolones against Pseudomonas aeruginosa. Morissey I; Smith JT Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593 [TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of penicillin minimal inhibitory and sub-inhibitory concentration on Staphylococcus aureus and Streptococcus faecium does not support the view that antibiotic sub-inhibitory concentrations can specifically interfere with bacterial virulence. Satta G; Rossi L; Bertoloni G; Cornaglia G; Canepari P; Fontana R Microbiologica; 1986 Jul; 9(3):305-19. PubMed ID: 3747854 [TBL] [Abstract][Full Text] [Related]
14. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria. Berlanga M; Montero MT; Hernández-Borrell J; Viñas M Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135 [TBL] [Abstract][Full Text] [Related]
15. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg]. Guibert J; Kitzis MD; Acar JF Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938 [TBL] [Abstract][Full Text] [Related]
18. Polyamine effects on antibiotic susceptibility in bacteria. Kwon DH; Lu CD Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056 [TBL] [Abstract][Full Text] [Related]
19. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment]. Soussy CJ; Le Van Thoi J; Duval J; Morel C; Malbruny B; Acar JF; Kitzis MD; Mounier M; Denis F; Courvalin P Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study on growth kinetics of organisms causing purulent infections in the presence of ofloxacin and ciprofloxacin]. Skala LZ Antibiot Khimioter; 1991 Nov; 36(11):21-4. PubMed ID: 1793289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]